Healthpeak Properties, Inc. (DOC) Stock Price & Analysis
Healthpeak Properties, Inc. (DOC) closed at USD 19.34 on Thursday, October 22, 2026, up 4.65% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 18.48; the Oct 22, 2026 session ranged USD 18.47–19.36 on volume of 7,368,487 shares. Market capitalization is $13.71B, with a 52-week range of USD 15.7–22.95 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 10:12 UTC.
Also available as compact Markdown for AI agents: nexqual.com/DOC.md
Key facts (DOC)
- 1 of 80 tracked superinvestors hold DOC (13F, Q2 2026): 0 new, 0 added, 1 reduced, 0 unchanged.
- Analysts: Hold (mean 2.55 on a 1–5 scale) (22 analysts), mean target USD 22.39 (range 17–29).
- Total return with dividends: 1Y +11.4% vs S&P 500 +14.9%; 5Y -25.6% vs S&P 500 +80.3%.
- Next earnings: 2026-11-02, EPS estimate USD 0.03, revenue estimate $744M.
Superinvestors (SEC 13F-HR, Q2 2026) (DOC)
1 of 80 tracked investors hold DOC. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Christopher Davis | Davis Advisors | 0.06% | $13.5M | Reduced -2.2% |
Analysts (DOC)
Consensus Hold (mean 2.55 on a 1–5 scale), 22 analysts; mean target USD 22.39 (low 17, high 29).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-19 | Wells Fargo | Target lowered | Equal-Weight | $22 → $19 |
| 2026-10-13 | UBS | Target lowered | Neutral | $21.5 → $20 |
| 2026-10-13 | Barclays | Target lowered | Equal-Weight | $24 → $21 |
| 2026-09-21 | Evercore ISI Group | Target lowered | In-Line | $23 → $22 |
| 2026-08-31 | Barclays | Target raised | Equal-Weight | $23 → $24 |
| 2026-08-13 | Baird | Target raised | Outperform | $21 → $24 |
| 2026-08-11 | Citigroup | Target raised | Neutral | $20 → $22 |
| 2026-08-10 | RBC Capital | Target raised | Outperform | $21 → $24 |
| 2026-08-06 | Cantor Fitzgerald | Target raised | Neutral | $20 → $23 |
| 2026-07-15 | Wells Fargo | Target raised | Equal-Weight | $20 → $22 |
| 2026-07-08 | UBS | Target raised | Neutral | $19 → $21.5 |
| 2026-07-07 | Barclays | Initiated | Overweight → Equal-Weight | $23 |
Total return (dividends reinvested) (DOC)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +11.4% | -25.6% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +11.5% | -5.7% |
| Volatility (annualized) | 29.1% | 26.4% |
| Max drawdown | -18.1% (Jul 2026→Oct 2026) | -51.2% (Dec 2021→Nov 2023) |
DOC analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $0.03 | $0.00 | — | $743.5M | 2 |
| Next quarter (ends Dec 2026) | $0.03 | $0.00 | — | $759.3M | 2 |
| Current fiscal year (ends Dec 2026) | $0.09 | $0.00 | — | $2.94B | 1 |
| Next fiscal year (ends Dec 2027) | $0.14 | $-0.15 | -193.3% | $3.17B | 2 |
Key Statistics (as of October 23, 2026 at 10:12 UTC)
| Price | USD 19.34 |
|---|---|
| Change | ▲ 4.65% (up) |
| Previous Close | USD 18.48 |
| Open | USD 18.56 |
| Day Range | USD 18.47 – 19.36 |
| 52-Week Range | USD 15.7 – 22.95 |
| Volume | 7,368,487 shares |
| Market Cap | $13.71B |
| Exchange | NYQ |
Technical Analysis (DOC)
Nexqual's technical model rates DOC "SELL" based on 2 bullish and 4 bearish signals across 127 daily candles, as of October 23, 2026 at 10:12 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 49.58 (neutral) |
| vs SMA50 | Below (USD 20.11) |
| MACD | -0.4 (negative) |
Analyst Ratings (DOC)
Wall Street analysts rate DOC "Hold" based on 22 analysts, with a mean price target of USD 22.39 (range USD 17–29), per Nexqual as of October 23, 2026 at 10:12 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 22 |
| Mean Target | USD 22.39 |
| High Target | USD 29 |
| Low Target | USD 17 |
| Buy / Hold / Sell | 8 / 14 / 0 |
Earnings (DOC)
| Next Earnings Date | 2026-11-02 |
|---|---|
| EPS Estimate | USD 0.03 |
| Revenue Estimate | $743.51M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 0.08 vs est 0.03 ▲ beat |
| 2026-03-31 | USD 0.28 vs est 0.06 ▲ beat |
| 2025-12-31 | USD 0.1 vs est 0.06 ▲ beat |
| 2025-09-30 | USD -0.18 vs est 0.06 ▼ miss |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Financials & Fundamentals (DOC)
| Total Revenue | $2.95B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +11.10% |
| Gross Margin | +57.65% |
| Operating Margin | +15.99% |
| Profit Margin | +8.25% |
| ROE | +3.04% |
| Debt / Equity | 1.09 |
| Current Ratio | 2.29 |
| Total Cash | $1.64B |
| Total Debt | $10.32B |
| Free Cash Flow (fiscal year ended Dec 2025, SEC 10-K) | $357.01M (12.6% of revenue) |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Financial Health Score (DOC)
Nexqual rates Healthpeak Properties, Inc.'s overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 10:12 UTC.
| Growth | Mixed — Revenue +4.0% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 58%, operating 16% (last 12 months) |
| Balance Sheet | Mixed — $1.64B cash vs $10.3B debt |
| Cash Flow | Solid — FCF $357M (FY ended Dec 2025, 10-K), 13% margin |
| Efficiency | Weak — ROE 3%, ROA 1.5% |
Ownership (DOC)
| Insider Ownership | +0.30% |
|---|---|
| Institutional Ownership | +97.83% |
| Shares Outstanding | 689.53M |
| Float | 686.69M |
| Short % of Float | +4.40% |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Leadership (DOC)
Healthpeak Properties, Inc. is led by Scott M. Brinker, President, CEO & Director, per Nexqual as of October 23, 2026 at 10:12 UTC.
| President, CEO & Director | Scott M. Brinker |
|---|---|
| Chief Financial Officer | Kelvin O. Moses |
| Senior Vice President of Investor Relations | Andrew Johns |
| Senior Vice President of Leasing - Outpatient Medical | James A. Croy |
| Senior VP, CFO and Controller of Senior Housing & Lab | Michelle Wood |
Major Backers & Investors (DOC)
Notable institutional backers of Healthpeak Properties, Inc. include JPMorgan, Fuller & Thaler Asset Management Inc., UNDISCOVERED MANAGERS Fd.S-Undiscovered Managers Behavioral Value Fd., according to Nexqual as of October 23, 2026 at 10:12 UTC.
Active Investors
| Investor | Stake |
|---|---|
| JPMorgan | 4.38% |
| Fuller & Thaler Asset Management Inc. | 4.22% |
| UNDISCOVERED MANAGERS Fd.S-Undiscovered Managers Behavioral Value Fd. | 3.25% |
| Invesco | 2.68% |
| Principal Financial Group, Inc. | 2.43% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 15% |
| BlackRock | 10.29% |
| State Street | 6.38% |
| Geode Capital | 3.58% |
| BNY Mellon | 2.21% |
Source: Nexqual, October 23, 2026 at 10:12 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| OHI | Omega Healthcare Investors, Inc | USD 46.3 | ▲ 4.16% |
| AHR | American Healthcare REIT, Inc. | USD 53.4 | ▲ 1.02% |
| CTRE | CareTrust REIT, Inc. | USD 36.62 | ▲ 2.72% |
| HR | Healthcare Realty Trust Incorpo | USD 17.93 | ▲ 4% |
| SBRA | Sabra Health Care REIT, Inc. | USD 19.6 | ▲ 3.7% |
| VTR | Ventas, Inc. | USD 86.99 | ▲ 1.89% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 10:12 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt